| Literature DB >> 22076131 |
Yiguang Zhu1, Fang Ji, Hui Shang, Qian Zhu, Pengxia Wang, Chengchen Xu, Yun Deng, Donghai Peng, Lifang Ruan, Ming Sun.
Abstract
Crystals in Bacillus thuringiensis are usually formed in the mother cell compartment during sporulation and are separated from the spores after mother cell lysis. In a few strains, crystals are produced inside the exosporium and are associated with the spores after sporulation. This special phenotype, named 'spore crystal association' (SCA), typically occurs in B. thuringiensis subsp. finitimus. Our aim was to identify genes determining the SCA phenotype in B. thuringiensis subsp. finitimus strain YBT-020. Plasmid conjugation experiments indicated that the SCA phenotype in this strain was tightly linked with two large plasmids (pBMB26 and pBMB28). A shuttle bacterial artificial chromosome (BAC) library of strain YBT-020 was constructed. Six fragments from BAC clones were screened from this library and discovered to cover the full length of pBMB26; four others were found to cover pBMB28. Using fragment complementation testing, two fragments, each of approximately 35 kb and located on pBMB26 and pBMB28, were observed to recover the SCA phenotype in an acrystalliferous mutant, B. thuringiensis strain BMB171. Furthermore, deletion analysis indicated that the crystal protein gene cry26Aa from pBMB26, along with five genes from pBMB28, were indispensable to the SCA phenotype. Gene disruption and frame-shift mutation analyses revealed that two of the five genes from pBMB28, which showed low similarity to crystal proteins, determined the location of crystals inside the exosporium. Gene disruption revealed that the three remaining genes, similar to spore germination genes, contributed to the stability of the SCA phenotype in strain YBT-020. Our results thus identified the genes determining the SCA phenotype in B. thuringiensis subsp. finitimus.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22076131 PMCID: PMC3208593 DOI: 10.1371/journal.pone.0027164
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Micrographs of parasporal crystals from transconjugants.
(A) Electron micrograph of a thin section of transconjugant with the SCA phenotype during sporulation. (B) Transconjugants with the SCA phenotype after sporulation; (C) Electron micrograph of a thin section of transconjugant with separated crystal during sporulation. (D) Transconjugants with separated crystal after sporulation. (A) and (C) were Grown for 20 h, Scale bar = 0.5 µm; the arrowheads indicate the exosporium. (B) and (D) were grown for 48 h and observed by phase-contrast microscopy. pc = parasporal crystal. Magnification, ×1,000.
Figure 2Phase-contrast micrographs of recombinant strains after growth for 48 h.
(A) BMB1151 (pBMB26-cured mutant of YBT-020). (B) Strain BMB1151 containing the 35 kb fragment of pBMB26. (C) Strain BMB171 containing the 35 kb fragment of pBMB26. (D) Strain BMB171 containing the fragments of pBMB26 and pBMB28. (E) Strain BMB171 containing the 35 kb fragment of pBMB28. Magnification, ×1,000.
Figure 3The search for minimal DNA fragments essential to the SCA phenotype in B. thuringiensis strain BMB171.
(A) Determination of the minimal sequence of pBMB275 (a fragment of pBMB26) in strain BMB171 harboring pBMB251A (a fragment of pBMB28). (B) Determination of the minimal sequence of pBMB251 (a fragment of pBMB28) in strain BMB171 harboring pBMB275A (a fragment of pBMB26). The ability of the region to recover SCA is indicated by “+”, and inability by “−”.
Figure 4Phase-contrast micrographs of different plasmid derivatives of pBMB275 and pBMB251 in strain BMB171 after growth for 48 h.
(A) Strain BMB171/pBMB251A+pBMB0617. (B) Strain BMB171/pBMB275A+pBMB251B2. (C) Strain BMB171/pBMB275A+pBMB251B3. (D) Strain BMB171/pBMB275A+pBMB251B5. (E) Strain BMB171/pBMB0617A+pBMB251B2. Magnification, ×1,000. Data not shown for pBMB251B4.
ORFs involved in the spore-crystal association (SCA) phenotype.
| Gene | Position | Size (aa) | Best BLAST match (source) | GenBank accession no. | % amino acids identity | reference |
| pBMB275 | ||||||
|
| 7026–10520 | 1164 | Cry26Aa [ | ABB51652 | 100 |
|
| pBMB251 | ||||||
|
| 18621–19523 | 300 | crystal protein NT40KD [ | AAL26871 | 30 |
|
|
| 19625–20431 | 268 | crystal protein NT32KD [ | AAL26870 | 22 |
|
|
| 20796–22238 | 480 | putative spore germination receptor [ | CAD30127 | 58 |
|
|
| 22231–23334 | 367 | putative spore germination receptor [ | CAD30126 | 54 |
|
|
| 23331–24461 | 376 | putative spore germination receptor [ | CAD30125 | 44 |
|
The numbers correspond to the nucleotide coordinates of inserted fragments in pBMB275 or pBMB251.
Figure 5Micrographs of mutant strains of YBT-020 and their corresponding complementary strains.
(A) and (B) Strain BMBJA (genes orf1 and orf2 disrupted). (C) and (D) Complementary strain BMBJA/pBMB251B5 (carrying orf1 and orf2). (E) Complementary strain BMBJA/pBMB251B5A (carrying a frameshift at the AccI site in orf1). (F) Complementary strain BMBJA/pBMB251B5B (carrying a frameshift at the EcoRI site in orf2). (G), (H) and (I) strain BMBJB (genes orf3, orf4, and orf5 disrupted). (J) Complementary strain BMBJB/pBMB252B3 (containing orf3, orf4, and orf5). (K) Strain BMBJ1 (gene cry26Aa disrupted); (L) Complementary strain BMBJ1/pBMB0617 (carrying the gene cry26Aa). (A), (C) and (G) Electron micrographs of a thin sections during sporulation, arrowheads indicate exosporium. Scale bar = 0.5 µm. (B), (D), (E), (F), (K) and (L) after Growth for 48 h. (H) after growth for 36 h. (I) and (J) after growth for for 36 h, 100 h. Magnification, ×1,000.
Bacterial strains and plasmids.
| Strain or plasmid | Description | Source or reference |
|
| ||
| YBT-020 |
|
|
| BMB171 | Acrystalliferous mutant of |
|
| BMB171R1 | BMB171R containing pBMB0617. | This work |
| BMB1151 | YBT-020 derivative, containing pBMB28 but cured of pBMB26 |
|
| BMBJ1 | YBT-020 derivative, with a chloromycetin insertion at | This work |
| BMBJA | YBT-020 derivative, with a chloromycetin insertion replacing the DNA fragment covering | This work |
| BMBJB | YBT-020 derivative, with a chloromycetin insertion replacing the DNA fragment covering | This work |
|
| ||
| DH5α | F- | |
| EPI300 | F−
| Epicentre |
| Plasmids | ||
| pHT304 |
|
|
| pDG1514 |
|
|
| pEG491 |
|
|
| pHT304Ts | Derivative of pHT304, containing temp-sensitive replicon, 6.8 kb | This work |
| pEMB0557 |
|
|
| pEMB0603 |
| unpublished |
| pBMB26 | 188 kb endogenous plasmid harboring |
|
| pBMB28 | 139 kb endogenous plasmid harboring |
|
| pBMB26-CmR | Derivative of pBMB26, with a chloromycetin insertion at | This work |
| pBMB275 | pEMB0557 containing a 35 kb fragment of pBMB26 | This work |
| pBMB275A | pEMB0603 containing a 35 kb fragment of pBMB26 | This work |
| pBMB0617 | pHT304 containing |
|
| pBMB0617A | pEMB0603 containing | This work |
| pBMB290 | pEMB0557 containing 16.7 kb | This work |
| pBMB291 | pEMB0557 containing 13.7 kb | This work |
| pBMB292 | pHT304 containing 6.3 kb | This work |
| pBMB251 | pEMB0557 containing a 35 kb fragment of p28 | This work |
| pBMB251A | pEMB0603 containing a 35 kb fragment of p28 | This work |
| pBMB251B1 | pHT304 containing 12.5 kb | This work |
| pBMB251B2 | pHT304 containing 7 kb | This work |
| pBMB251B3 | pHT304 containing 5.3 kb | This work |
| pBMB251B4 | pHT304 containing 1.7 kb | This work |
| pBMB251B5 | pHT304 containing 2.9 kb | This work |
| pBMB251B5A | pBMB251B5 derivative carrying frameshift mutation at | This work |
| pBMB251B5B | pBMB251B5 derivative carrying frameshift mutation at | This work |
Ampr, ampicillin resistance; Cmr, Chloromycetin resistance. Ermr, erythromycin resistance; Kanr, kanamycin resistance; Tetr, Tetracycline resistance.
Primers used for PCR.
| Primer | Sequence | Construct(s) | Use |
| cry26-F |
| pBMB0617A | Heterologous expression |
| cry26-R |
| ||
| 251B1 |
| pBMB251B5 | Heterologous expression |
| 251B2 |
| ||
| 251B4 |
| pEMBJA | Gene disruption |
| 251B5 |
| ||
| 251B6 |
| pEMBJB | Gene disruption |
| 251B7 |
| ||
| 251B8 |
| pEMBJB | Gene disruption |
| 251B9 |
| ||
| cry26A |
| pEMBJ1 | Gene disruption |
| cry26B |
| ||
| CM1 |
| pEMBJ1 | Gene disruption |
| CM2 |
|